Comments on“Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer”by Cao et al,Chin Med J 1999;112:430-432
对的评价“有 yttrium-90 玻璃的肝的 radioembolization 为主要的肝癌症的治疗的微范围”由 Cao 等，下巴 Med J 1999；112：430-432。作者机构：Chinese Univ Hong Kong Prince Wales Hosp Dept Surg Shatin Hong Kong Peoples R China Chinese Univ Hong Kong Prince Wales Hosp Dept Clin Oncol Shatin Hong Kong Peoples R China
出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)
年 卷 期：2001年第114卷第4期
页 面：97-98页
核心收录：
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题：yttrium Comments on
摘 要：Editors, We would like to congratulate Cao and his colleagues on the extremely good mean survival rate of 19.5 months achieved in 17 patients with non-resectable liver cancer (16 primary and 1 metastatic).1 Because the results of their study sounds so promising, centres having access to glass yttrium-90 (90Y) microspheres may want to try their methods. It is therefore necessary to clarify some of the points mentioned in their report.
维普期刊数据库
同方期刊数据库